Monoclonal antibodies against Stx1B subunit of Escherichia coli O157:H7 distinguish the bacterium from other bacteria

被引:8
作者
Li, G. [1 ,2 ]
Hong, J. [1 ]
Huo, G. [2 ]
Ren, X. [1 ]
机构
[1] NE Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China
[2] NE Agr Univ, Coll Food Sci, Harbin 150030, Peoples R China
基金
中国国家自然科学基金;
关键词
enterohaemorrhagic Escherichia coli (EHEC); infection; monoclonal antibody; Stx1B; HEMOLYTIC-UREMIC SYNDROME; SHIGA-TOXIN; CATTLE; VEROTOXIN-1; PREVALENCE; EXPRESSION; TOXICITY; STRAINS; BINDING; O157-H7;
D O I
10.1111/j.1472-765X.2010.02919.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: The Shiga-like toxins (Stx) are critical virulence factors of enterohaemorrhagic Escherichia coli (EHEC). Stx1B subunit plays important roles in EHEC infection. This work aims to generate and characterize monoclonal antibodies (mAbs) against the Stx1B and to investigate their utility in discrimination ELISA. Methods and Results: Two newly identified mAbs (designated 2H8 and 1B10, respectively) against the Stx1B protein were prepared via hybridoma techniques. The immunoreactivity of both mAbs to the Stx1B protein was confirmed in ELISA and Western blot. Moreover, they differentiate EHEC from Salmonella enteritis, non-Stx1-producing E. coli, Mycobacterium tuberculosis, Listeria monocytogenes, Streptococcus agalactiae and Staphylococcus aureus. Conclusions: The anti-STx1B mAbs are valuable diagnostic reagents for distinguishing EHEC from other bacteria. Significance and Impact of the Study: This is the first report regarding the usage of anti-STx1B mAbs in discrimination ELISA. The established ELISA may have potential in clinical surveillance of EHEC infection.
引用
收藏
页码:499 / 503
页数:5
相关论文
共 23 条
  • [1] Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits
    Bast, DJ
    Brunton, JL
    Karmali, MA
    Richardson, SE
    [J]. INFECTION AND IMMUNITY, 1997, 65 (06) : 2019 - 2028
  • [2] Duration of detection of fecal excretion of Escherichia coli O157:H7 in cattle
    Besser, TE
    Hancock, DD
    Pritchett, LC
    McRae, EM
    Rice, DH
    Tarr, PI
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) : 726 - 729
  • [3] Safety and Pharmacokinetics of Chimeric Anti-Shiga Toxin 1 and Anti-Shiga Toxin 2 Monoclonal Antibodies in Healthy Volunteers
    Bitzan, Martin
    Poole, Ruth
    Mehran, Mariam
    Sicard, Eric
    Brockus, Catherine
    Thuning-Roberson, Claire
    Riviere, Marc
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 3081 - 3087
  • [4] Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves
    DeanNystrom, EA
    Bosworth, BT
    Cray, WC
    Moon, HW
    [J]. INFECTION AND IMMUNITY, 1997, 65 (05) : 1842 - 1848
  • [5] ESCHERICHIA-COLI O157 - H7 AND ITS SIGNIFICANCE IN FOODS
    DOYLE, MP
    [J]. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 1991, 12 (04) : 289 - 302
  • [6] Easton L, 1997, BRIT J BIOMED SCI, V54, P57
  • [7] SITE OF ACTION OF A VERO TOXIN (VT2) FROM ESCHERICHIA-COLI O157-H7 AND OF SHIGA TOXIN ON EUKARYOTIC RIBOSOMES - RNA N-GLYCOSIDASE ACTIVITY OF THE TOXINS
    ENDO, Y
    TSURUGI, K
    YUTSUDO, T
    TAKEDA, Y
    OGASAWARA, T
    IGARASHI, K
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 171 (1-2): : 45 - 50
  • [8] THE EPIDEMIOLOGY OF INFECTIONS CAUSED BY ESCHERICHIA-COLI O157-H7, OTHER ENTEROHEMORRHAGIC ESCHERICHIA-COLI, AND THE ASSOCIATED HEMOLYTIC UREMIC SYNDROME
    GRIFFIN, PM
    TAUXE, RV
    [J]. EPIDEMIOLOGIC REVIEWS, 1991, 13 : 60 - 98
  • [9] Cloning, Prokaryotic Expression, and Biological Analysis of Recombinant Chicken IFN-γ
    Li, Guangxing
    Zeng, Yan
    Yin, Jiechao
    Lillehoj, Hyun S.
    Ren, Xiaofeng
    [J]. HYBRIDOMA, 2010, 29 (01): : 1 - 6
  • [10] Production and characterization of monoclonal antibodies reactive with the chicken interleukin-15 receptor alpha chain
    Li, GX
    Lillehoj, HS
    Min, WG
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2001, 82 (3-4) : 215 - 227